Researchers from the Wellcome Sanger Institute, the University of Cambridge and collaborators have uncovered the interplay between cancer-driving genetic mutations and inherited genetic variants in a ...

New national surveillance data announced at the UK Health Security Agency (UKHSA) annual conference has demonstrated an increase in antibiotic resistant infections and associated deaths in England.

Researchers from University College London (UCL) and UCL’s London Hospital’s NHS Foundation Trust (UCLH) have found that better use of existing drugs improved survival rates and decreased the ...

The Cardiff site is one of up to 30 sites that will eventually open across the UK as part of the trial The Welsh site is one of up to 30 other sites set to open around the UK. Estimated to affect over ...

The US government has announced the ten drugs selected for the first round of pricing negotiations under President Biden’s Inflation Reduction Act (IRA). The IRA allows Medicare, the government health ...

The US Food and Drug Administration (FDA) has approved the over-the-counter (OTC), non-prescription use of Harm Reduction Therapeutics’s RiVive, a 3mg naloxone hydrochloride nasal spray, for the ...

Astellas Pharma and Cullgen have announced a research collaboration and exclusive option agreement aimed at advancing targeted protein degraders, with the deal potentially worth up to $1.9bn. Protein ...

The US health department has proposed three new models to help lower the cost of drugs, promote accessibility and improve quality of care for those enrolled in voluntary government health insurance ...

The Healthcare Communications Association (HCA) has collaborated on a new mental health initiative after research revealed that more than 90% of communications professionals experienced poor mental ...

BioNTech has announced it will acquire UK AI start-up InstaDeep in a deal worth up to £562m, following the company’s initial equity investment as part of InstaDeep’s Series B financing round in ...

A new COVID-19 subvariant, XBB.1.5, is causing concern in the US, where it has been spreading rapidly since December. Data from the US Centers for Disease Control and Prevention (CDC) has estimated ...

Merck & Co – known as MSD outside the US and Canada – and Moderna have announced positive phase 2b trial results investigating the use of their personalised mRNA cancer vaccine, mRNA-4157/V940, in ...